Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | SPATS2L |
| Upstream (Parents) |
|---|
| (<<) FBN1 → SPATS2L |
| (<<) HLA-DQA2///HLA-DQA1 → SPATS2L |
| (<<) ZEB1 → SPATS2L |
| (<<) GPR116 → SPATS2L |
| (<<) NOTCH2NL → SPATS2L |
| (<<) CD93 → SPATS2L |
| Downstream (Children) |
|---|
| SPATS2L → SH3PXD2A (>>) |
| SPATS2L → SOCS7 (>>) |
| SPATS2L → TAF13 (>>) |
| SPATS2L → SUSD5 (>>) |
| SPATS2L → PCDH7 (>>) |
| SPATS2L → ZNF549 (>>) |
| SPATS2L → PPP1R12B (>>) |
| SPATS2L → CYP26B1 (>>) |
| SPATS2L → CPE (>>) |
| SPATS2L → CMAH (>>) |
| SPATS2L → NRCAM (>>) |
| SPATS2L → HMGB1L12 (>>) |
| SPATS2L → WNT2B (>>) |
| SPATS2L → ZEB1 (>>) |
| SPATS2L → ULBP1 (>>) |
| SPATS2L → GUSBP3///SMA5///SMA4 (>>) |
| SPATS2L → SYNJ1 (>>) |
| SPATS2L → KCNN1 (>>) |
| SPATS2L → TNNI3 (>>) |
| SPATS2L → ETV5 (>>) |
| SPATS2L → CASP4 (>>) |
| SPATS2L → ARHGEF17 (>>) |
| SPATS2L → KRTAP5-8 (>>) |
| SPATS2L → ITPR1 (>>) |
| SPATS2L → NOTCH2NL (>>) |
| SPATS2L → ADAM11 (>>) |
